Jun 09, 2021 / 02:30PM GMT
Terence C. Flynn - Goldman Sachs Group, Inc., Research Division - MD
Hi. Good morning, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. biopharma analyst here at Goldman Sachs, and we're very pleased to be hosting Alkermes today at our virtual conference.
Today from the company, we have Richard Pops, who is Chairman and CEO of Alkermes. Rich, thanks so much for taking the time out of your day to join us today. I'll turn it over to you for some opening remarks, and then we'll launch into some Q&A.
Richard F. Pops - Alkermes plc - Chairman & CEO
Perfect. Great. Thanks. It's good to see you, Terence. And sorry, we're not all in person. But as we said before, this may be the last time we have to do it this way. So let's hope that's the case.
Terence C. Flynn - Goldman Sachs Group, Inc., Research Division - MD
Fingers crossed.
Richard F. Pops - Alkermes plc - Chairman & CEO
I won't take long because I'd rather have the conversation, but I just -
Alkermes Plc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers